SNMMI: PET prostate image lands Image of the Year honors

June 8, 2015

Research using a PET radiotracer for prostate cancer that can be labeled with different radioisotopes for diagnostic or therapeutic use won Image of the Year honors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

The emerging imaging technique, developed at Heidelberg University Hospital and the German Cancer Research Center, uses a prostate-specific membrane antigen (PSMA) inhibitor called PSMA-617 to target the enzyme on the surface of prostate cancer cells, even if they have metastasized to other organs. PSMA-617 can be radiolabeled with gallium-68 (Ga-68) for diagnostic use and radiolabeled with lutetium-177 (Lu-177) for therapy.

Full Story